Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Hesham Amin, MD is a board certified pathologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Illinois, and Illinois.
Education & Training
Loyola University Medical CenterFellowship, Hematopathology, 2000 - 2001- Loyola University Medical CenterResidency, Pathology-Anatomic and Clinical, 1997 - 2000
George Washington University School of MedicineInternship, Transitional Year, 1996 - 1997
Cairo University School of MedicineClass of 1982
Certifications & Licensure
TX State Medical License 2002 - 2027
IL State Medical License 2000 - 2026- IL State Medical License 2000 - 2026
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Hematology
Publications & Presentations
PubMed
- 1 citationsCirculating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma.Shadi Chamseddine, Betul Gok Yavuz, Yehia I Mohamed, Sunyoung S Lee, James C Yao
Journal of Immunotherapy and Precision Oncology. 2024-11-01 - 2 citationsTissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma.Michael LaPelusa, Shadi Chamseddine, Hop Sanderson Tran Cao, Lianchun Xiao, Elshad Hasanov
Oncology. 2024-10-18 - Genome-wide association study identifies high-impact susceptibility loci for HCC in North America.Manal M Hassan, Donghui Li, Younghun Han, Jinyoung Byun, Rikita I Hatia
Hepatology. 2024-07-01
Press Mentions
The C-jun and JunB Transcription Factors Facilitate the Transit of Classical Hodgkin Lymphoma Tumour Cells Through G1October 30th, 2018
Pioneering Alum's $10.5 Million Gift Boosts Biomedical Research at Houston Graduate SchoolJune 26th, 2017- Kopchicks' $10.5 Million Gift to Fund Student Fellowships at MD Anderson UTHealth Graduate SchoolJune 22nd, 2017
Grant Support
- A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC PatientsUNIVERSITY OF TX MD ANDERSON CAN CTR2021–2026
